Evaluation of the Efficacy and Safety of Molnupiravir Treatment in Mild/Moderate Covid-19 Patients.

NCT06223932 · clinicaltrials.gov ↗

UNKNOWN

Status

2600

Enrollment

OTHER

Sponsor class

Conditions

COVID-19
SARS-CoV-2 Infection

Interventions

DRUG: Molnupiravir

Sponsor

Serap Yavuz

Collaborators

[object Object]